Walleye Capital LLC Myriad Genetics Inc Put Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$13.91 - $21.32 $27,820 - $42,640	-2,000 Reduced 66.67%	1,000 $19,000
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $47,970 - $69,660	3,000 New	3,000 $48,000
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $115,115 - $193,050	-5,500 Reduced 70.51%	2,300 $63,000
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $172,224 - $367,224	7,800 New	7,800 $223,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $45,340 - $70,000	-2,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $53,860 - $69,400	2,000 New	2,000 $66,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.